Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

Introduction: Immunotherapy represents a key pillar of cancer treatments, with high response rates and long survival. Its use is increasing, mainly at the expense of the geriatric population due to the ageing of this population. However, despite its benefit, its safety in certain areas such as cardi...

Full description

Bibliographic Details
Main Authors: Irene Toribio-García, Alejandro Olivares-Hernández, José Pablo Miramontes-González, Luis Posado Domínguez, Ana Martín García, Rocío Eiros Bachiller, Luis Figuero-Pérez, María Garijo Martínez, Jonnathan Roldán Ruiz, Lorena Bellido Hernández, Emilio Fonseca-Sánchez, Pedro Luis Sánchez, Edel del Barco-Morillo
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Cancers
Subjects:
immunotherapy
immune checkpoint inhibitors
elderly
cardiotoxicity
real-word data
Online Access:https://www.mdpi.com/2072-6694/15/17/4293

Internet

https://www.mdpi.com/2072-6694/15/17/4293

Similar Items